B7-H2 Is a Costimulatory Ligand for CD28 in Human
Open Access
- 28 April 2011
- journal article
- research article
- Published by Elsevier BV in Immunity
- Vol. 34 (5), 729-740
- https://doi.org/10.1016/j.immuni.2011.03.014
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 35 references indexed in Scilit:
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell ResponsesImmunity, 2007
- Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiencyBlood, 2006
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiencyNature Immunology, 2003
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002
- Initial sequencing and analysis of the human genomeNature, 2001
- CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.The Journal of Experimental Medicine, 1995
- CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xLImmunity, 1995
- Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.The Journal of Experimental Medicine, 1994
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994